These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives. Barton M, Filardo EJ, Lolait SJ, Thomas P, Maggiolini M, Prossnitz ER. J Steroid Biochem Mol Biol; 2018 Feb; 176():4-15. PubMed ID: 28347854 [Abstract] [Full Text] [Related]
8. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells. Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M. Breast Cancer Res; 2012 Jan 17; 14(1):R12. PubMed ID: 22251451 [Abstract] [Full Text] [Related]
9. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers. Hernández-Silva CD, Villegas-Pineda JC, Pereira-Suárez AL. Front Endocrinol (Lausanne); 2020 Jan 17; 11():544. PubMed ID: 32973677 [Abstract] [Full Text] [Related]
10. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Lappano R, Rosano C, Santolla MF, Pupo M, De Francesco EM, De Marco P, Ponassi M, Spallarossa A, Ranise A, Maggiolini M. Curr Cancer Drug Targets; 2012 Jun 17; 12(5):531-42. PubMed ID: 22414008 [Abstract] [Full Text] [Related]
11. GPER and Testicular Germ Cell Cancer. Chevalier N, Hinault C, Clavel S, Paul-Bellon R, Fenichel P. Front Endocrinol (Lausanne); 2020 Jun 17; 11():600404. PubMed ID: 33574796 [Abstract] [Full Text] [Related]
12. GPER mediates activation of HIF1α/VEGF signaling by estrogens. De Francesco EM, Pellegrino M, Santolla MF, Lappano R, Ricchio E, Abonante S, Maggiolini M. Cancer Res; 2014 Aug 01; 74(15):4053-64. PubMed ID: 24894716 [Abstract] [Full Text] [Related]
13. Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors. Lu AS, Rouhimoghadam M, Arnatt CK, Filardo EJ, Salem AK. Mol Pharm; 2021 Mar 01; 18(3):1455-1469. PubMed ID: 33600191 [Abstract] [Full Text] [Related]
14. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors. Albini A, Rosano C, Angelini G, Amaro A, Esposito AI, Maramotti S, Noonan DM, Pfeffer U. Curr Med Chem; 2014 Mar 01; 21(9):1129-45. PubMed ID: 24304271 [Abstract] [Full Text] [Related]
15. Homology Modeling, Validation and Dynamics of the G Protein-coupled Estrogen Receptor 1 (GPER-1). Bruno A, Aiello F, Costantino G, Radi M. Mol Inform; 2016 Sep 01; 35(8-9):333-9. PubMed ID: 27546037 [Abstract] [Full Text] [Related]
16. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Cheng SB, Graeber CT, Quinn JA, Filardo EJ. Steroids; 2011 Aug 01; 76(9):892-6. PubMed ID: 21354433 [Abstract] [Full Text] [Related]
17. Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prossnitz ER, Barton M. Prostaglandins Other Lipid Mediat; 2009 Sep 01; 89(3-4):89-97. PubMed ID: 19442754 [Abstract] [Full Text] [Related]
18. Phytoestrogens and breast cancer prevention: possible mechanisms of action. Mense SM, Hei TK, Ganju RK, Bhat HK. Environ Health Perspect; 2008 Apr 01; 116(4):426-33. PubMed ID: 18414622 [Abstract] [Full Text] [Related]
19. Interactions of isoflavones and other plant derived estrogens with estrogen receptors for prevention and treatment of breast cancer-considerations concerning related efficacy and safety. Leclercq G, Jacquot Y. J Steroid Biochem Mol Biol; 2014 Jan 01; 139():237-44. PubMed ID: 23274118 [Abstract] [Full Text] [Related]
20. [GPER receptor - the new player in estrogen signaling]. Cygankiewicz AI, Jacenik D, Krajewska WM. Postepy Biochem; 2015 Jan 01; 61(1):52-60. PubMed ID: 26281354 [Abstract] [Full Text] [Related] Page: [Next] [New Search]